Increased circulating β(2)-adrenergic receptor autoantibodies are associated with smoking-related emphysema

Smoking is a dominant risk factor for chronic obstructive pulmonary disease (COPD) and emphysema, but not every smoker develops emphysema. Immune responses in smokers vary. Some autoantibodies have been shown to contribute to the development of emphysema in smokers. β(2)-adrenergic receptors (β(2)-A...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jia-yi, Liu, Bei-bei, Du, Yi-peng, Zhang, Yuan, Zhang, Yi-wei, Zhang, You-yi, Xu, Ming, He, Bei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338268/
https://www.ncbi.nlm.nih.gov/pubmed/28262783
http://dx.doi.org/10.1038/srep43962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338268/
https://www.ncbi.nlm.nih.gov/pubmed/28262783
http://dx.doi.org/10.1038/srep43962

Ejemplares similares